Precision Biosensor is dedicated to be a leading POCT – in vitro diagnostics manufacturer with the expertise in developing a next-generation platform technology of Europium-based Time Resolved Fluorescence (TRF) immunochromatography assay for the growing IVD market. Our vision is to provide confidence in making clinical decisions with our leading diagnostic solutions and improve quality of patient healthcare.
Precision Biosensor, based in Daejeon, Korea, is established in 2015 by merging two companies of Terawave and Nanoditech.
Nano-Ditech Corp. was founded in 2002 in New Jersey, USA, with the specialty in development of high quality rapid immuno-diagnostic reagents to serve the point-of-care market place including medical professionals, physicians, clinical laboratories and hospitals. Nano-Ditech is proud to be among the few that have a track record for successfully developing test assays from development of raw materials to obtaining US FDA and CE clearance. Nano-Ditech is now a subsidiary company, focused on developing new test assays based on TRF technology for Precision Biosensor.
Terawave was founded in 2009 in Daejeon, Korea. Before its establishment, Terawave had developed the first Korean space payloads of astrophysics, which were the primary and secondary payloads of KITSAT-1, KITSAT-II launched in 2003. With this specialty, they developed UV spectrographic system for bio application in 2004, and continued to develop analysis system for In-Vitro Diagnosis. The core technology of Terawave is detection and measurement of photon with distinguished opto-mechanical and electro-optic technology for the field of bio-medicals, especially In-Vitro Diagnostics.